Fingerprint
Dive into the research topics of 'Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma
Seunggu J. Han, John D. Rolston, Annette M. Molinaro, Jennifer L. Clarke, Michael D. Prados, Susan M. Chang, Mitchel S. Berger, Ashley DeSilva, Nicholas A. Butowski
Research output: Contribution to journal › Article › peer-review
39
Scopus
citations